Authors: CHASTY RC MYINT H OSCIER DG ORCHARD JA BUSSUTIL DP HAMON MD PRENTICE AG COPPLESTONE JA

Citation: Rc. Chasty et al., AUTOIMMUNE HEMOLYSIS IN PATIENTS WITH B-CLL TREATED WITH CHLORODEOXYADENOSINE (CDA), Leukemia & lymphoma, 29(3-4), 1998, pp. 391-398

Authors: ORCHARD JA BOLAM S OSCIER DG

Citation: Ja. Orchard et al., ASSOCIATION OF MYELODYSPLASTIC CHANGES WITH PURINE ANALOGS, British Journal of Haematology, 100(4), 1998, pp. 677-679

Authors: CHASTY RC MYINT H OSCIER DG ORCHARD JA BUSUTTIL DP HAMON MD PRENTICE AG COPPLESTONE JA

Citation: Rc. Chasty et al., AUTOIMMUNE HEMOLYSIS IN PATIENTS WITH B-CELL TREATED WITH CHLORODEOXYADENOSINE (CDA), British Journal of Haematology, 93, 1996, pp. 274-274

Authors: ORCHARD JA BOLAM S OSCIER DG

Citation: Ja. Orchard et al., INCIDENCE OF DYSPLASTIC CHANGES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AFTER TREATMENT WITH PURINE ANALOGS, Blood, 88(10), 1996, pp. 3562-3562

Authors: BOLAM S ORCHARD JA MYINT H OSCIER DG

Citation: S. Bolam et al., FLUDARABINE IS EFFECTIVE IN THE TREATMENT OF SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES (SLVL), Blood, 88(10), 1996, pp. 2272-2272

Authors: MYINT H ORCHARD JA FIGES AE TILLER M

Citation: H. Myint et al., COMPARISON OF CYCLOPHOSPHAMIDE 1.5 GM M(2) WITH G-CSF VS 3-4 GM/M(2) WITH G-CSF FOR THE MOBILIZATION OF PBPC IN HEAVILY PRETREATED PATIENTSWITH HEMATOLOGICAL MALIGNANCIES/, Blood, 86(10), 1995, pp. 1622-1622